Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy.

Saved in:
Bibliographic Details
Title: Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy.
Authors: Hashim A; Department of Gastroenterology, King's College Hospital, London, United Kingdom., Patten PEM; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.; Department of Haematology, King's College Hospital, London, United Kingdom., Kuhnl A; Department of Haematology, King's College Hospital, London, United Kingdom., Ooft ML; Department of Pathology, King's College Hospital, London, United Kingdom., Hayee B; Department of Gastroenterology, King's College Hospital, London, United Kingdom., Sanderson R; Department of Haematology, King's College Hospital, London, United Kingdom.
Source: Inflammatory bowel diseases [Inflamm Bowel Dis] 2021 Mar 15; Vol. 27 (4), pp. e45-e46.
Publication Type: Case Reports; Letter
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9508162 Publication Model: Print Cited Medium: Internet ISSN: 1536-4844 (Electronic) Linking ISSN: 10780998 NLM ISO Abbreviation: Inflamm Bowel Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1536-4844
DOI:10.1093/ibd/izaa320